PERCUTANEOUS ALLERGEN IMMUNOTHERAPY USING HYDROPHILIC GEL PATCH

Title:

PERCUTANEOUS ALLERGEN IMMUNOTHERAPY USING HYDROPHILIC GEL PATCH

Document Type and Number:

Japanese Patent JP2016210684

Kind Code:

A

Abstract:

PROBLEM TO BE SOLVED: To provide percutaneous immune preparations useful for transdermal immunization.SOLUTION: The transdermal preparation of the invention is characterized by that an antigen or artificial synthesis nucleic acid is laminated on a base surface to control immune response by being applied on the intact skin. A typical antigen is allergen. Preferably, a base is a hydrophilic gel having adhesiveness. Particularly, a hydrophilic gel, a base, consists of hyaluronic acid, glycerin, Cosmol 13, and HiPAS 10, and optimally the weight ratio thereof is 0.02:3:4.5:10 in this order.SELECTED DRAWING: Figure 1

More Like This:

JP2004521867	Vaccine immunotherapy for immunosuppressed patients
JP2005526692	Immunogenic conjugates of carbohydrate haptens and agglutinating protein carriers
WO/2004/031105	USE OF A33 ANTIGENS AND JAM-IT

Inventors:

GON EISHUKU
KAMIYAMA FUMIO
NAKAGAWA SHINSAKU
OKADA NAOTAKA
HIROBE SHOKO

Application Number:

JP2013227544A

Publication Date:

December 15, 2016

Filing Date:

October 16, 2013

Export Citation:

Click for automatic bibliography generation Help

Assignee:

KOSUMEDEI SEIYAKU KK
UNIV OSAKA

International Classes:

A61K39/00; A61K9/70; A61K39/35; A61K47/10; A61K47/14; A61K47/32; A61K47/36

Previous Patent: Hydroxamic acid derivative

Next Patent: Lamination lock